Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 701–800 of 971
FISETIN – A PROSPECTIVE NEUROPROTECTIVE AGENT WITH MULTI-MOLECULAR TARGET ‘S: A REVIEWPreprint
Ravula, A. R., Teegala, S. B., Pasangulapati, J. P., Perumal, V., Shanker, K., & Boyina, H. K. (2024) · Authorea · doi:10.22541/au.170665458.88955468/v1 · Cited by 2
Maltsev, A. V., Dovidchenko, N. V., Uteshev, V. K., Sokolik, V. V., Shtang, O. M., Yakushin, M. A., Sokolova, N. M., Surin, A. K., & Galzitskaya, O. V. (2013) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750813040057 · Cited by 2
NRN1 may Modulate Tau Phosphorylation and Neuronal Apoptosis in AD via the PIGU-CASP3 Axis
Cheng, W., Zhang, J., Zhu, H., Wang, Z., Li, M., Wang, J., Fu, H., Zhang, Y., Gao, Y., Chen, C., et al. (2025) · Current Alzheimer Research · doi:10.2174/0115672050361366250328040542 · Cited by 2
Bases moleculares de la enfermedad de Alzheimer. Perspectivas de nuevos enfoques terapéuticos
Huete‐Pérez, J. A., & Sentis, E. (2007) · Encuentro · doi:10.5377/encuentro.v0i78.3668 · Cited by 2
Effect of the Icelandic Mutation APPA673T in the Murine APP Gene on Phenotype of Line 66 Tau Mice
Anschuetz, A., Robinson, L., Mondésir, M., Melis, V., Platt, B., Harrington, C. R., Riedel, G., & Schwab, K. (2025) · Biomolecules · doi:10.3390/biom16010028 · Cited by 2
Goncalves, K., & Przyborski, S. A. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01628 · Cited by 2
Favre-Besse, F.-C. (2012) · theses.fr (ABES) · doi:10.70675/5bb71069z5b5az4767zaea3zf859650fb47d · Cited by 2
Use of a Neurotrophic Factor Mimetic to Block Amyloid Toxicity in Alzheimer's Disease Models
Rawal, D. (2010) · Digital WPI · Cited by 2
Agius, L. M. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00070-7 · Cited by 2
Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration
Ferrero, H., Larráyoz, I. M., Solas, M., Martínez, A., Ramírez, M. J., & Gil-Bea, F. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1079-8 · Cited by 2
Rzechorzek, N. M. (2015) · ERA · Cited by 2
Tau Repeats Disassemble Amyloid-β Fibrils In Vitro by Interacting with KLVFFA and GGVVIA Domains
Yoon, S., Deidesheimer, A. T., Seo, W., Lysenko, A., Park, I., Ye, S., Cho, I., Kim, H. Y., & Kim, Y. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00759 · Cited by 2
Regulation of Zn2+ and aggregation affects Aβ1-42- induced changes in cell culture viability.
Potemkin, N. (2017) · Otago University Research Archive (University of Otago) · Cited by 2
Etude des interactions des dérivés de la Thioflavine T avec les agrégats amyloïdes
Yona, R. L. (2009) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 2
Turcu, S., Glavce, C. S., & Tatomirescu, L. F. (2026) · Psychiatry International · doi:10.3390/psychiatryint7010023 · Cited by 1
Shin, J., Suh, S. J., Park, Y. J., Lee, S., Kang, J., Lee, E. S., Jung, H. N., Ryoo, I., 이성인, Eo, J. S., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70447 · Cited by 1
The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential
Shu, D., Fu, C., Liu, Z., & Li, C. (2026) · FEBS Journal · doi:10.1111/febs.70574 · Cited by 1
E2F4 as a single multifactorial target against Alzheimer’s diseasePreprint
López‐Sánchez, N., Ramón‐Landreau, M., Trujillo, C., Garrido‐García, A., & Frade, J. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.082784 · Cited by 1
Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease
Rossi, D. P. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Domise, M. (2018) · theses.fr (ABES) · doi:10.70675/43c1f12fze623z41e8z970fz64a5de94a299 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Murtishaw, A. S. (2014) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/6456429 · Cited by 1
Rubin, M., Naik‐Talapadatur, A., Majerová, P., Hrabě, J., Kováč, A., & Hrabětová, S. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70460 · Cited by 1
Sergeant, N., & Buée, L. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_4 · Cited by 1
Mitochondria, neurosteroids and biological rhythms : implications in health and disease states
Grimm, A. (2015) · theses.fr (ABES) · doi:10.70675/8aac5aa9z77cdz49bdz9cf5z0ff0b5dd0f84 · Cited by 1
Effect of brain DHA levels on cytoskeleton expression.
Hasio, A.-C., Chen, J.-J., Chung, W.-L., & Su, H. (2008) · PubMed · Cited by 1
Takalo, M. (2015) · UEF eRepo (University of Eastern Finland) · Cited by 1
Jackson, T. A., & Najem, M. S. (2012) · Digital WPI · Cited by 1
Adhikari, R. (2019) · Digital Commons - Michigan Tech (Michigan Technological University) · doi:10.37099/mtu.dc.etdr/891 · Cited by 1
Murtishaw, A. S. (2018) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/14139891 · Cited by 1
From Protein Tangles to Genetic Variants: The Central Role of Tau in Neurodegenerative Disease
Julia, H., & Wade‐Martins, R. (2011) · InTech eBooks · doi:10.5772/29839 · Cited by 1
Structure, Function, and Regulation of the Microtubule Associated Protein Tau
Bunker, J. M., & Feinstein, S. C. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-336-3_21 · Cited by 1
Immunotherapy for the Treatment of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00009-4 · Cited by 1
Somogyi, A., & Wolf, E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.721773 · Cited by 1
Genetic Characterisation of Neurodegenerative disorders
Fung, H. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Azul de Metileno na Paralisia Supranuclear Progressiva, uma possibilidade?
Vilaça, C. D. O., Pessôa, B. L., Orsini, M. A., Reis, C. H. M., Azizi, M. A. A., Moreno, A. M., Bastos, V. H., & Leite, M. A. A. (2020) · Revista Neurociências · doi:10.34024/rnc.2020.v28.10210 · Cited by 1
Microglial glutathione and glutamate: regulation mechanisms
Fry, V. A. H. (2009) · UCL Discovery (University College London) · Cited by 1
Prion Protein Misfolding at the Synapse
Šišková, Z., Perry, V. H., & Asuni, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_15 · Cited by 1
Otth, C., Leyton, L., Salamin, M., Acuña, F., Martín, C., & Concha, M. I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160508 · Cited by 1
Musardo, S. (2016) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/s-musardo_phd2016-01-11 · Cited by 1
Tackenberg, C. (2016) · Matters · doi:10.19185/matters.201602000028 · Cited by 1
Cortical Excitability and its Relationship with Clinical Symptoms in Alzheimer’s Dementia
Joseph, S. (2021) · TSpace (University of Toronto) · Cited by 1
Català-Solsona, J. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Rovina, D. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/rovina-davide_phd2014-01-24 · Cited by 1
Florent‐Béchard, S. (2006) · theses.fr (ABES) · doi:10.70675/96a974b7z63fcz4825z8e71z7301b5907b67 · Cited by 1
The role of neurotrophic factors in Alzheimers disease
Kemppainen, S. (2018) · UEF eRepo (University of Eastern Finland) · Cited by 1
6th Belgian Brain Congress: The gene-environment tango in the healthy and diseased brain
Van Malderen, S., Rinaldi, R., Vicenzutto, A., Lefebvre, L., & Pham, T. H. (2016) · doi:10.3389/978-2-88919-978-5 · Cited by 1
Drosophila melanogaster como modelo de la pérdida sináptica temprana en la enfermedad de Alzheimer
López‐Arias, B. (2012) · Biblos-e Archivo (Universidad Autónoma de Madrid) · Cited by 1
O papel dos biomarcadores na doença de Alzheimer
Gomes, M. A. C. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Alteraciones de los Astrocitos en el envejecimiento y en la enfermedad del Alzheimer
Matas, S. G. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Molina‐Porcel, L. (2016) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Alzheimer´s disease neuropathology and inflammation: A genetic and immunohistochemical study
Kok, E. (2011) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Maina, M. B. (2017) · Sussex Research Online (University of Sussex) · Cited by 1
The Role of the Human Tau 3'-Untranslated Region in Regulating Tau Expression
Dickson, J. R. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Sonois, V. (2007) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 1
Búsqueda de compuestos antiamiloidogénicos con potencial terapéutico en la enfermedad de Alzheimer
Aliaga, K. L. J. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Plouffe, V. (2011) · doi:10.71781/32113 · Cited by 1
Matsuno, T. (2010) · InTech eBooks · doi:10.5772/8575 · Cited by 1
All MAPT out?: Well-travelled pathways into neurodegeneration
Wray, S., & Hardy, J. (2010) · The Biochemist · doi:10.1042/bio03202014 · Cited by 1
Sorrentino, S. (2019) · BOA (University of Milano-Bicocca)
The long distance relationship of regional amyloid burden and tau pathology spreadPreprint
Hoenig, M. C., Doering, E., Bischof, G. N., Drzezga, A. E., van Eimeren, T., & Initiative, T. A. D. N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.15.575698
Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials
Gobbi, S., Silvestri, E., Tonietto, M., Klein, G., van den Heuvel, M. P., & Magon, S. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70259
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Plascencia‐Villa, G., & Perry, G. (2026) · Neuromethods · doi:10.1007/978-1-0716-5234-3_7
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
Kirkwood, C. M. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Fertan, E. (2017) · DalSpace (Dalhousie University)
Untersuchungen zur Rekrutierung myeloischer Zellen in einem Tiermodell der Alzheimerschen Erkrankung
Schlevogt, B. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1158
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Studies on the Involvement of the Immune system in Alzheimer's disease
Marcello, A. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3277
Hvoslef‐Eide, M. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Zhu, S. (2011) · Mspace (University of Manitoba)
Chronic stress and glucocorticoid actions in brain plasticity and Tau pathology
Dioli, C. (2021) · theses.fr (ABES) · doi:10.70675/b812791ezcc0az4036zb746z0d9b5daacfab
Begcevic, I. (2018) · TSpace (University of Toronto)
Deregulation of oxidative phosphorylation system and energy homeostasis in Alzheimer's disease
Rhein, V. F. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005042311
CERAMIDE-ENRICHED EXTRACELLULAR VESICLES
Elsherbini, A. M. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.474
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationPreprint
Zare, A., Salehi, S., Briese, M., & Sendtner, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549639
TRAFFICKING OF α-SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Farmacologiche, S., Farmacia, F. D., Farmacotossicologiche, S., & Ciclo, X. (2011)
TRAFFICKING OF ALPHA SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Saraceno, C. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/saraceno-claudia_phd2012-02-08
Wang, L., & Campioni, S. (2011) · InTech eBooks · doi:10.5772/20922
Flavonoids as regulators of amyloid precursor protein processing
Cox, C. J. (2014) · The University of Bath Online Publications Store (The University of Bath)
New Small Molecule Drug Discovery for Alzheimer's Disease
Liu, K., Zhang, M., & Nagappan, G. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-6
Tackenberg, C. (2009) · osnaDocs (Osnabrück University)
Amyloid β hypothesis in the development of therapeutic agents for Alzheimer's disease
Adeniji, A. O., Johnson, C., & Mody, V. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00020-x
Développement de formes vectorisables innovantes dans le cadre de maladies liées à l'âge
Iskandar, S. (2019) · theses.fr (ABES) · doi:10.70675/1d771122z75d0z4ba8z8ee6zbd1a858ffc38
Pollock, N. M. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-1mp9-zz91
Mutant ubiquitin and the proteasome in Alzheimer's disease
de Vrij, F. M. S. (2005) · UvA-DARE (University of Amsterdam)
Multilingualism and the risk of Alzheimer disease and dementia
Hack, E. E. (2011) · UWSpace (University of Waterloo)
The involvement of degradation pathways and neuron-to-neuron transmission in Alzheimer’s disease
Agholme, L. (2012) · DiVA (Linkoping University)
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.